{
  "@context": {
    "schema": "https://schema.org/",
    "fabio": "http://purl.org/spar/fabio/",
    "cito": "http://purl.org/spar/cito/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "bibo": "http://purl.org/ontology/bibo/",
    "go": "http://purl.obolibrary.org/obo/GO_",
    "doid": "http://purl.org/obo/DOID_",
    "chebi": "http://purl.org/obo/CHEBI_",
    "atc": "http://purl.org/obo/ATC_",
    "pw": "http://purl.org/obo/PW_",
    "eco": "http://purl.org/obo/ECO_",
    "mondo": "http://purl.org/obo/MONDO_",
    "comptox": "https://comptox.epa.gov/",
    "mesh": "http://id.nlm.nih.gov/mesh/"
  },
  "@id": "https://doi.org/10.1234/example",
  "@type": "bibo:AcademicArticle",
  "dcterms:title": "CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer’s disease",
  "dcterms:creator": [
    {
      "@id": "https://orcid.org/0000-0002-1234-5678",
      "@type": "foaf:Person",
      "foaf:name": "Qiang Qiang"
    },
    {
      "@id": "https://orcid.org/0000-0002-2345-6789",
      "@type": "foaf:Person",
      "foaf:name": "Loren Skudder-Hill"
    },
    {
      "@id": "https://orcid.org/0000-0002-3456-7890",
      "@type": "foaf:Person",
      "foaf:name": "Tomoko Toyota"
    },
    {
      "@id": "https://orcid.org/0000-0002-4567-8901",
      "@type": "foaf:Person",
      "foaf:name": "Zhe Huang"
    },
    {
      "@id": "https://orcid.org/0000-0002-5678-9012",
      "@type": "foaf:Person",
      "foaf:name": "Wenshi Wei"
    },
    {
      "@id": "https://orcid.org/0000-0002-6789-0123",
      "@type": "foaf:Person",
      "foaf:name": "Hiroaki Adachi"
    }
  ],
  "dcterms:abstract": "Alzheimer's disease is a neurodegenerative disorder characterized pathologically by amyloid-beta plaques, tau tangles, and neuronal loss. Our study investigates the role of CSF 14-3-3β in cognitive decline in Alzheimer's disease by analyzing data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We found that higher CSF 14-3-3β levels correlate with cognitive impairment and other Alzheimer's disease biomarkers, indicating its potential as a diagnostic tool.",
  "schema:datePublished": "2023-11-20",
  "schema:keywords": [
    "Alzheimer’s disease",
    "14-3-3β",
    "CSF",
    "biomarker",
    "dementia"
  ],
  "fabio:hasPublicationVenue": {
    "@id": "https://doi.org/10.1234/journal123",
    "@type": "fabio:Journal",
    "schema:name": "Alzheimer's Research & Therapy"
  },
  "fabio:hasPart": [
    {
      "@id": "#introduction",
      "@type": "fabio:Section",
      "dcterms:title": "Introduction",
      "fabio:hasContent": "Alzheimer’s disease is a chronic neurodegenerative disorder that affects millions of people worldwide, especially those over the age of 65."
    },
    {
      "@id": "#methods",
      "@type": "fabio:Section",
      "dcterms:title": "Materials and methods",
      "fabio:hasContent": "We sourced participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), ensuring a diverse sample for our analyses."
    },
    {
      "@id": "#results",
      "@type": "fabio:Section",
      "dcterms:title": "Results",
      "fabio:hasContent": "Our findings indicate that increased CSF 14-3-3β levels correlate highly with the progression of Alzheimer’s disease."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1038/s41586-020-XXXX",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "The role of biomarkers in Alzheimer's disease.",
      "bibo:doi": "10.1038/s41586-020-XXXX"
    },
    {
      "@id": "https://doi.org/10.1111/j.1471-4159.2020.01000.x",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Longitudinal study of cognitive decline in Alzheimer's disease.",
      "bibo:doi": "10.1111/j.1471-4159.2020.01000.x"
    }
  ],
  "cito:discusses": [
    {
      "@id": "GO:0008150",
      "schema:name": "biological_process"
    },
    {
      "@id": "DOID:14330",
      "schema:name": "lung cancer"
    }
  ]
}